.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
AFFIRM-AHF evaluated intravenous ferric carboxymaltose in patients hospitalized with acute heart failure who also had iron deficiency. Patients received treatment around the time of discharge and were followed for recurrent heart-failure hospitalizations and cardiovascular death. Although the primary composite outcome did not achieve conventional statistical significance for the combined endpoint, ferric carboxymaltose reduced recurrent heart-failure hospitalizations, supporting a clinically relevant effect on post-discharge morbidity. The study is important because iron deficiency is common in heart failure and may contribute to fatigue, reduced exercise capacity and poorer outcomes even when anemia is not severe. For internists, the practical issue is systematic identification of iron deficiency rather than assuming that hemoglobin alone captures the problem. Ferritin and transferrin saturation can help define patients who may benefit from replacement. Intravenous therapy can be particularly useful when rapid repletion is needed or oral absorption is limited. The broader message is that guideline-directed heart-failure care extends beyond conventional neurohormonal therapy: correcting important comorbid biologic deficits may reduce rehospitalization and improve functional status.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
AFFIRM-AHF evaluated intravenous ferric carboxymaltose in patients hospitalized with acute heart failure who also had iron deficiency. Patients received treatment around the time of discharge and were followed for recurrent heart-failure hospitalizations and cardiovascular death. Although the primary composite outcome did not achieve conventional statistical significance for the combined endpoint, ferric carboxymaltose reduced recurrent heart-failure hospitalizations, supporting a clinically relevant effect on post-discharge morbidity. The study is important because iron deficiency is common in heart failure and may contribute to fatigue, reduced exercise capacity and poorer outcomes even when anemia is not severe. For internists, the practical issue is systematic identification of iron deficiency rather than assuming that hemoglobin alone captures the problem. Ferritin and transferrin saturation can help define patients who may benefit from replacement. Intravenous therapy can be particularly useful when rapid repletion is needed or oral absorption is limited. The broader message is that guideline-directed heart-failure care extends beyond conventional neurohormonal therapy: correcting important comorbid biologic deficits may reduce rehospitalization and improve functional status.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
4 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
